Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Huang S et al. – Downregulation of ZNF423 expression by RNA interference in neuroblastoma cells results in a growth advantage and resistance to RA–induced differentiation, whereas overexpression of ZNF423 leads to growth inhibition and enhanced differentiation. Low ZNF423 expression is associated with poor disease outcome in neuroblastoma patients.

Related Articles

Fingering Modulators of Retinoic Acid Signaling Identifies New Prognostic Marker for Neuroblastoma
Cancer Cell, 10/01/09    Relevance Score: 80%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address